Additional file 3: of Rituximab versus azathioprine as therapy for maintenance of remission for anti-neutrophil cytoplasm antibody-associated vasculitis (RITAZAREM): study protocol for a randomized controlled trial

Gopaluni, Seerapani; Smith, Rona; Lewin, Michelle; McAlear, Carol; Mynard, Kim; Jones, Rachel; Specks, Ulrich; Merkel, Peter; Jayne, David

doi:10.6084/m9.figshare.c.3711532_D3.v1

13063_2017_1857_MOESM3_ESM.doc (68 kB)

Additional file 3: of Rituximab versus azathioprine as therapy for maintenance of remission for anti-neutrophil cytoplasm antibody-associated vasculitis (RITAZAREM): study protocol for a randomized controlled trial

journal contribution

posted on 2017-03-07, 05:00 authored by Seerapani Gopaluni, Rona Smith, Michelle Lewin, Carol McAlear, Kim Mynard, Rachel Jones, Ulrich Specks, Peter Merkel, David Jayne

RITAZAREM trial flow chart; RITAZAREM study schema. (DOC 68 kb)

Funding

Arthritis Research UK

History

Usage metrics

Keywords

ANCA-associated vasculitis RITAZAREM Rituximab Azathioprine Randomized clinical trial

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Additional file 3: of Rituximab versus azathioprine as therapy for maintenance of remission for anti-neutrophil cytoplasm antibody-associated vasculitis (RITAZAREM): study protocol for a randomized controlled trial

Funding

Arthritis Research UK

History

Usage metrics

Categories

Keywords

Licence

Exports